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Summary
Objectives:  To  evaluate  the  clinical  outcomes  of  total  laryngectomy  (TL),  complications  and
factors affecting  survival.
Design:  Retrospective  review  of  hospital  electronic  database  for  head  and  neck  squamous  cell
carcinoma  (SCCa).
Setting:  Large  district  general  hospital  in  England,  United  Kingdom.
Participants:  Patients  who  had  TL  between  January  1994  and  January  2008.
Main outcome  measures:  5-year  disease  speciﬁc  survival  (DSS)  and  disease-free  survival  (DFS).
Results and  conclusions:  Seventy-one  patients  were  reviewed,  of  whom  38  (54%)  had  laryn-
geal SCCa  and  33  (46%)  hypopharyngeal  SCCa.  The  overall  mean  survival  period  following  TL
was 42.4  months.  The  5-year  DSS  and  DFS  was  better  for  laryngeal  SCCa  compared  to  hypopha-
ryngeal  SCCa,  although  not  statistically  signiﬁcant  (P  =  0.090,  P  =  0.54  respectively).  Patients
treated for  laryngeal  SCCa  had  a  mean  survival  period  of  47.5  months  compared  to  36.5  months
for hypopharyngeal  disease.  Those  who  had  laryngeal  recurrence  after  primary  radiotherapy
(RT) demonstrated  statistically  better  survival  probability  than  those  who  had  hypopharyn-
geal recurrence  (P  =  0.011).  Patients  without  cervical  lymphadenopathy  had  statistically  better
survival (P  =  0.049).  The  most  common  early  complication  was  related  to  the  cardiorespiratory
system. One  fatal  complication  of  erosion  of  the  brachiocephalic  artery  due  to  the  laryngectomy
tube was  noted.  The  most  common  late  complication  was  neopharyngeal  stenosis.  The  com-
monest cause  of  death  was  due  to  locoregional  recurrence,  followed  by  medical  co-morbidities.
Patients referred  to  specialised  head  and  neck  clinic  had  a  better  survival  probability  than  those
referred to  a  general  ENT  clinic  (P  =  0.37).  While  there  is  increasing  tendency  towards  laryngeal
conservation,  total  laryngectomy  remains  a  robust  treatment  option  in  selected  patients.
© 2012  Published  by  Elsevier  Masson  SAS.∗ Corresponding author.
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oi:10.1016/j.anorl.2011.10.012ntroductionaryngeal  cancer  is  the  commonest  carcinoma  of  the  head
nd  neck  region  [1].  In  2005,  2190  patients  were  diag-
osed  in  the  United  Kingdom  and  caused  800  deaths  in  2006
2].  Despite  advances  in  chemo-radiotherapy  (RT),  surgery
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continues  to  play  an  important  role  in  the  management  of
laryngeal  cancer.  Laryngeal  preservation  techniques  such
as  endoscopic  laser  resection  have  been  increasing  popu-
lar.  However,  total  laryngectomy  (TL)  remains  a  reasonable
option  for  advanced  disease  in  selected  patients.
Whilst  there  are  numerous  studies  comparing  outcomes
of  different  treatment  arms  for  laryngeal  carcinoma,  there
are  scarce  data  on  patients  who  have  undergone  TL,
especially  with  regards  to  long-term  outcome  and  prog-
nosis.  Outcome  data  would  improve  our  ability  to  council
these  patients  regarding  important  therapeutic  decisions
and  end-of-life  issues.  The  aim  of  this  paper  was  to
retrospectively  evaluate  the  clinical  outcomes  of  TL,  post-
operative  complications  and  factors  affecting  survival  rate.
The  impact  of  surgery  on  quality  of  life  (QoL)  was  not
included  in  this  review  as  not  all  patients  had  QoL  evalu-
ation,  especially  those  who  had  surgery  at  the  beginning  of
the  review  period.  Furthermore,  it  was  not  possible  to  ret-
rospectively  evaluate  QoL  issues  as  some  of  the  patients  had
died.
Methods
Patients
The  ENT  Department  at  Derby  Hospitals  NHS  Foundation
Trust  is  part  of  the  regional  head  and  neck  cancer  net-
work  covering  southern  Derbyshire  and  eastern  Staffordshire
(England,  UK),  serving  a  population  of  over  800,000.  A  ret-
rospective  review  of  the  departmental  electronic  cancer
database  was  undertaken  between  January  1994  and  Jan-
uary  2008.  Patients  who  had  TL  for  squamous  cell  carcinoma
(SCCa)  of  the  larynx  and  hypopharynx  were  included,  as
were  those  who  had  TL  as  a  salvage  procedure  for  recurrence
following  either  primary  RT  or  transoral  CO2 laser  resec-
tion  (TOLR).  Recurrence  was  deﬁned  as  histological  evidence
of  lesion  at  least  12  months  after  completion  of  the  pri-
mary  treatment.  Patients  with  primary  cervical  oesophageal
cancers  and  those  who  had  less  than  6  months  follow-up
were  excluded.  The  departmental  database  and  patient
case  notes  were  reviewed  for  epidemiological  data,  tumour
stage,  complications  and  survival  outcomes.
All  patients  were  staged  according  to  the  International
Union  Against  Cancer  (UICC,  2002)/American  Joint  Commis-
sion  on  Cancer  (AJCC,  2002)  staging  system.  Preoperative
staging  of  tumour  was  performed  by  endoscopy  and  radi-
ological  imaging  (CT  neck  and  chest).  The  management
of  all  patients  was  discussed  at  the  head  and  neck  multi-
disciplinary  team  (MDT)  meeting.  Patients  were  counselled
regarding  possible  treatment  options  and  informed  consent
for  TL  was  obtained.  All  patients  received  a  primary  tracheo-
oesophageal  puncture,  which  was  used  for  feeding  until  oral
intake  was  established.  Therapeutic  neck  dissection  was
performed  at  the  time  of  laryngectomy  in  patients  with
cervical  node  involvement.  All  operations  were  performed
by  either  JS  or  SM,  who  were  the  senior  surgeons  in  the
department.  Postoperative  RT  was  given  to  the  primary  site
and  neck  based  on  clinicopathological  risk  factors  includ-
ing  status  of  resection  margins,  perineural  invasion,  lymph
node  involvement  and  the  presence  of  extracapsular  nodal
spread.
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Complications  were  categorised  as  early  and  late  onset.
arly  complications  were  deﬁned  as  those  arising  within
our  weeks  of  surgery  and  late  complications  were  those
ccurring  subsequently.  Where  patients  had  died  in  the  com-
unity,  their  General  Practitioner  (GP)  was  contacted  to
btain  the  date  and  cause  of  death.  The  standard  follow-
p  regime  in  our  institution  following  TL  is  monthly  review
n  the  1st  year,  2-monthly  in  the  2nd  year,  4-monthly  in  the
rd  and  4th  year  and  6-monthly  in  the  5th  year.  Patients  are
ormally  discharged  from  follow-up  after  5  years  but  were
dvised  to  return  if  they  had  any  concerns.  In  addition,  all
atients  had  access  to  the  Clinical  Nurse  Specialist  in  Head
nd  Neck  Cancer,  including  those  who  had  been  discharged.
thical  considerations
nstitutional  Review  Board  approval  was  not  required  for  this
etrospective  review.  The  encrypted  electronic  database
as  kept  on  a  hospital  computer  in  a  secured  location,
ccessed  only  by  password.
tatistical  analysis
tatistical  analysis  of  the  data  was  performed  with  SPSS  14.0
omputer  software  (SPSS  Inc.,  IL,  USA).  All  survival  probabil-
ties  were  estimated  by  using  the  Kaplan-Meier  method  from
he  day  of  TL.  Log-rank  tests  (Cox  Mantel)  were  performed
o  compare  differences  between  the  estimates.  Results  were
egarded  as  statistically  signiﬁcant  if  P  ≤  0.05.  The  cumula-
ive  5-year  disease  speciﬁc  survival  (DSS)  and  disease-free
urvival  (DFS)  probabilities  were  evaluated.  Mean  survival
eriod,  together  with  standard  error  (SE)  and  95%  conﬁdence
nterval  (95%  CI)  were  also  calculated.
esults
he  review  period  spanned  14  years.  Seventy-one  patients
61  males,  10  females)  fulﬁlled  the  inclusion  criteria  for
his  study.  The  mean  age  of  patients  was  64  years  (range
0—84  years).  The  postoperative  follow-up  period  ranged
rom  6  months  to  128  months  (mean  42  months).  Patients
tayed  in  hospital  for  an  average  of  16  days  (range  12—20)
fter  surgery.
Thirty-eight  (54%)  patients  were  diagnosed  with  laryngeal
CCa  and  33  (46%)  had  hypopharyngeal  SCCa.  Most  of  the
atients  (83%)  presented  with  either  T3  or  T4  SCCa  (Table  1)
nd  had  Stage  IV  disease.  The  remaining  17%  had  T1  or  T2
umours  at  presentation,  all  of  whom  had  previously  under-
one  either  RT  or  TOLR.  Of  the  54  patients  who  had  surgery
s  the  primary  treatment  modality,  46  (65%)  had  TL  and  eight
11%)  total  laryngo-pharyngectomy  (two  jejunal  free-ﬂap,
ix  gastric  pull-up  reconstruction  procedure).  The  remaining
7  (24%)  patients  had  salvage  surgery,  of  whom  16  (23%)  had
reviously  been  treated  with  RT  and  one  patient  had  TOLR.
f  these,  15  patients  had  TL  and  two  had  total  laryngo-
haryngectomy  and  jejunal  free-ﬂap  reconstruction.  Nearly
alf  of  the  cohort  (48%)  had  neck  dissection  procedures  at
he  time  of  laryngeal  resection.
Although  there  were  no  intra-operative  complications,  24
arly  postoperative  complications  were  recorded  (Table  2).
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Table  1  Clinical  stages  of  laryngeal  cancer  (n  =  38)  and  hypopharyngeal  cancer  (n  =  33).
Larynx  (n  =  38)  Untreated  Previously  treated
T2  T3  T4  Total  T1  T2  T3  T4  Total
N0 3 2 9 14 4 2a 4 1  10
N1 1  3  4  1  1
N2 1  5  6  1  1
N3 1  1
Total  3  4  18  25  4  2  5  1  13
Hypopharynx  (n  =  33)  Untreated  Previously  treated
T2 T3 T4 Total T2 T4 Total
N0 2  11  13
N1 1  1  3  5  1  2  3
N2 1  7  8  2  2
N3 2  2
Total 1  4  23  28  1  4  5
a Includes one patient previously treated with transoral CO2 laser resection.
Table  2  Summary  of  early  and  late  complications.
Description  Number  of  cases  (%)
Early  complication
Pneumonia  4  (17)
Cardiac  arrhythmias  4  (17)
Hypocalcemia  4  (17)
Pharyngo-cutaneous  ﬁstula  3  (13)
Wound  haematoma  2  (8)
Deep vein  thrombosis  2  (8)
Wound  infection 2  (8)
Chyle leak 2 (8)
Erosion  of  brachiocephalic  artery 1  (4)
Total 24  (100)
Late complications
Neopharyngeal  stenosis 4 (29)
Tracheo-stomal  stenosis  3  (21)
Tracheo-oesophageal  puncture
related
3 (21)
Neuroma  of  the  neck  1  (6)
Oesophageal  stricture  1  (6)
Pharyngeal  leak  1  (6)
Hypothyroidism  1  (6)
Jejunal  anastomotic  stenosis  1  (6)
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the laryngectomy  tube  was  noted.  The  most  common  late
complication  was  neopharyngeal  stenosis  (29%),  followed
by  trachea-stomal  stenosis  (21%)  and  problems  with  the
tracheo-oesophageal  puncture  site  (Table  2).  Both  cases  of
oesophageal  and  jejunal  anastomotic  stenosis  were  dilated
endoscopically.  There  was  one  case  of  hypothyroidism,
which  required  long-term  thyroxine  replacement.
Twenty-six  patients  (36.6%)  remained  alive  during  the
review  period  (Fig.  1),  of  whom  11  had  been  treated  for
laryngeal  SCCa  and  15  for  hypopharygeal  SCCa.  The  com-
monest  cause  of  death  was  due  to  locoregional  recurrence
(36%),  followed  by  medical  co-morbidities  (Table  3).  There
were  eight  (11.3%)  recorded  cases  of  distant  metastasis,
the  most  common  being  to  the  lung.  Six  patients  (8.5%)
had  a  second  primary  cancer  diagnosed.  The  average  time
interval  to  diagnosis  of  the  second  primary  was  17.6  months
(range  3—55).  The  overall  mean  survival  period  following
TL  was  42.4  months  (SE  2.8,  95%  CI  37.0—47.9).  Survival
outcome  was  not  statistically  signiﬁcant  between  the  maleTotal 14  (100)
he  most  common  was  related  to  the  cardiorespiratory
ystem  (34%),  frequently  associated  with  pre-existing  medi-
al  co-morbidities.  Transient  hypocalcaemia  which  resolved
rior  to  hospital  discharge  was  recorded  in  four  cases.  All
ases  of  chyle  leak  and  pharyngo-cutaneous  ﬁstula  (PCF)
ere  managed  conservatively.  Of  the  three  cases  with  PCF,
nly  one  patient  had  primary  RT  prior  to  TL.  The  two
ases  of  wound  infection,  managed  conservatively  with
ntibiotics,  did  not  result  in  wound  dehiscence.  One  fatal
omplication  of  erosion  of  the  brachiocephalic  artery  due  to
Figure  1  Laryngeal  and  hypopharyngeal  squamous  cell  car-
cinoma,  5-year  disease  speciﬁc  survival  (DSS)  compared.  NS
(P =  0.090).
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Table  3  Cause  of  death  following  total  laryngectomy.
Cause  of  death  Number  of  deaths  (%)
Erosion  of  brachiocephalic  artery  1  (2)
Locoregional  recurrence  16  (36)
Distant  metastasis
Lung  6  (14)
Liver 1  (2)
Bone 1  (2)
Second  primary  carcinoma
Bronchogenic 2 (4)
Oesophagus 2 (4)
Tonsil 1  (2)
Tongue  1  (2)
Medical  co-morbidities
Cardiovascular  disease  6  (14)
End-stage  respiratory  disease  3  (7)
Bronchopneumonia  3  (7)
Acute renal  failure  1  (2)
Septicaemia  1  (2)
Figure  3  Previously  treated  laryngeal  and  hypopharyngeal
squamous  cell  carcinoma  5-year  disease  speciﬁc  survival  (DSS)
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and  female  cohorts  (P  =  0.75).  The  overall  DSS  and  DFS
was  0.39  and  0.54  respectively  at  5  years.  Although  the  5-
year  DSS  (Fig.  2)  and  DFS  (Fig.  3)  was  better  for  laryngeal
SCCa  compared  to  hypopharyngeal  SCCa,  the  difference  was
not  statistically  signiﬁcant  (P  =  0.090,  P  =  0.54  respectively).
Patients  treated  for  laryngeal  SCCa  had  a  mean  survival
period  of  47.5  months  (SE  3.4,  95%  CI  40.9—54.2)  compared
to  36.5  months  (SE  4.3,  95%  CI  28.0—45.0)  for  hypopharyn-
geal  disease.
Those  who  had  laryngeal  recurrence  after  primary
RT  demonstrated  statistically  better  survival  probability
than  those  who  had  hypopharyngeal  recurrence  (P  =  0.011,
Fig.  3).  These  patients  survived  a  mean  of  53.2  months  (SE
4.7,  95%  CI  44.1—62.4)  compared  to  19.6  months  (SE  6.0,
95%  CI  7.9—31.3)  in  those  with  recurrent  hypopharyngeal
Figure  2  Laryngeal  and  hypopharyngeal  squamous  cell  car-
cinoma  5-year  disease-free  survival  (DFS)  rates  compared.  NS
(P =  0.54).
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isease.  The  mean  period  to  recurrence  after  completion
f  primary  RT  was  12.9  months  (range  0—53)  for  laryn-
eal  SCCa  and  14.5  months  (range  0—72)  for  hypopharyngeal
CCa.  Patients  who  had  TL  as  the  primary  treatment  modal-
ty  for  laryngeal  SCCa  demonstrated  a  non-signiﬁcant  trend
owards  poorer  survival  (mean  44.5  months,  SE  4.5,  95%  CI
5.7—53.2)  than  primary  RT.  However,  patients  who  had
rimary  TL  for  hypopharyngeal  SCCa  had  better  survival
robability  (P  =  0.127)  compared  to  those  who  had  primary
T.  Those  who  had  surgery  survived  a  mean  of  39.5  months
SE  4.7,  95%  CI  30.2—48.7)  compared  to  19.6  months  (SE  6.0,
5%  CI  28.0—45.0)  in  patients  who  had  primary  RT.  Of  the
4  patients  who  had  TL  as  the  primary  treatment  modal-
ty,  83%  were  Stage  IV  disease  at  presentation.  The  mean
urvival  period  for  Stage  IV  laryngeal  SCCa  was  44.8  months
SE  4.6,  95%  CI  35.8—53.8),  compared  to  36.2  months  (SE
.7,  95%  CI  26.9—45.4)  for  Stage  IV  hypopharyngeal  SCCa
P  =  0.333).
Laryngeal  SCCa  patients  who  were  N0  at  presenta-
ion  had  statistically  better  survival  (P  =  0.049),  averaging
1.9  months  (SE  3.9,  95%CI  44.7—59.1),  compared  to  those
ho  were  N  positive  (mean  38.7  months,  SE  6.2,  95%  CI
6.5—50.9).  This  trend  was  similarly  observed  in  hypopha-
yngeal  SCCa,  although  it  did  not  achieve  statistically
igniﬁcance  (P  =  0.122).  Those  without  cervical  involvement
urvived  a  mean  of  46.3  months  (SE  6.9,  95%  CI  32.7—59.9),
ompared  to  31.5  months  (SE  5.1,  95%  CI  28.0—45.0)  in  those
ho  had  cervical  lymphadenopathy.
Twenty-two  patients,  referred  by  their  GPs  with  a  suspi-
ion  of  head  and  neck  cancer,  were  seen  within  two  weeks
average  10  days)  in  a  rapid  access  specialised  clinic,  as  rec-
mmended  by  current  national  guidelines  [11]. The  mean
uration  from  ﬁrst  clinic  appointment  to  operation  was
3.7  days  (SE  37.1).  The  remaining  patients  were  identiﬁed
n  routine  ENT  clinics  or  after  referral  from  other  non-
pecialised  hospital  clinicians,  with  the  average  duration
rom  referral  to  ENT  clinic  appointment  of  21.4  days  (SE
2.4,  range  2—46)  and  the  average  duration  from  clinic
ppointment  to  operation  of  53  days  (SE  34.5).  No  statistical
ifference  in  survival  probability  was  noted  between  these
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wo  groups  (P  =  0.37),  although  patients  who  had  been  seen
ithin  two  weeks  had  better  survival.
iscussion
ynopsis  of  key  ﬁndings
he  overall  survival  rate  was  36.6%,  with  a  mean  survival
eriod  of  42.4  months  after  surgery.  Patients  with  primary
aryngeal  cancers  had  better  survival  probabilities  than
hose  with  hypopharyngeal  cancers.  Those  who  had  salvage
urgery  for  laryngeal  recurrence  had  signiﬁcantly  better  sur-
ival  probability  than  hypopharyngeal  recurrence.  Advanced
odal  and  T  stage  were  both  poor  prognostic  indicators  for
urvival.  There  was  a  non-signiﬁcant  survival  advantage  in
atients  who  had  primary  surgery  compared  with  those  who
ad  salvage  surgery  for  recurrence  after  RT.  Interestingly,
t  was  observed  that  patients  who  had  salvage  surgery  for
aryngeal  SCCa  had  better  survival  than  those  who  under-
ent  TL  as  the  primary  treatment  modality,  although  this
rend  was  not  statistically  signiﬁcant.
omparisons  with  other  studies
atients  with  hypopharyngeal  cancer  had  poorer  survival
utcome  than  those  with  laryngeal  cancer,  comparable
ith  results  reported  by  Hall  et  al.  [3].  Likewise,  patients
ith  recurrent  laryngeal  cancer  had  longer  mean  survival
eriod  than  those  with  recurrent  hypopharyngeal  cancer  [4].
toekli  et  al.  reported  that  the  5-year  DSS  for  39  cases  after
alvage  TL  was  0.63,  with  mortality  rate  of  49%.  In  contrast,
he  overall  mortality  after  salvage  surgery  in  this  study  was
5%.  Other  studies  have  reported  poorer  mortality  rates,
s  high  as  85%  at  25  months  follow-up  in  20  salvage  cases
eported  by  Young  et  al.  [5].  The  present  overall  5-year  DSS
as  poorer  than  some  reported  studies.  In  a  cohort  of  83
tage  IV  laryngeal  SCCa  studied  by  Spector  et  al.,  the  5-year
SS  was  higher  at  0.45,  although  the  reported  DFS  of  0.29
as  lower  than  this  study  [6].  The  overall  complication  rate
f  38%  was  lower  than  that  reported  by  Hall  et  al.  (48%)  [3].
o  ﬂap  failure  was  reported  in  this  study.
haryngo-cutaneous  ﬁstula  formation
he  reported  incidence  of  PCF  formation  after  laryngec-
omy  varies  from  6.5%  to  20%  in  larger  case  series  [3,5,7,8].
nly  a  small  proportion  of  patients  (4%)  in  this  study  suf-
ered  with  a  PCF.  This  may  be  due  to  the  higher  rate  of
rimary  TL  (75%)  performed  compared  to  salvage  laryngec-
omy.  It  is  also  our  department’s  practice  to  commence  early
nteral  feeding  via  the  primary  tracheo-oesophageal  ﬁstula
ather  than  naso-gastric  tube  until  contrast  swallow  con-
rms  anastomotic  integrity.  Wakisaka  et  al.  encountered  a
7%  rate  of  PCF  after  TL  in  their  cohort  of  63  cases  [9].
hey  reported  an  increased  incidence  of  PCF  formation  in
atients  who  had  prior  RT  or  combination  chemo-RT,  and
oncluded  that  the  addition  of  chemotherapy  to  irradiation
elays  PCF  closure.  In  addition,  Boscolo-Rizzo  et  al.  reported
hat  diabetes  mellitus,  preoperative  hypoalbuminemia,
hronic  pulmonary  diseases  and  chronic  hepatopathy  were
c
P
n
hS.C.  Leong  et  al.
ndependent  predictors  for  PCF  formation  [10]. The  low
umber  of  cases  in  this  study  precluded  multivariate  analysis
or  correlation  of  risk  factors  to  occurrence  of  PCF.
-week  wait  (2WW)  rule  for  suspected  head  and
eck cancer
atients  referred  under  the  2WW  rule  had  better  survival
utcome  than  those  referred  conventionally,  although  the
ifference  was  not  statistically  signiﬁcant.  Whilst  this  may
emonstrate  the  beneﬁts  of  rapid  referral,  earlier  diagnosis
nd  surgery,  other  factors  also  play  a part  including  discus-
ion  in  a  formal  MDT  and  introduction  of  national  guidelines
or  the  management  of  head  and  neck  cancer  [11]. The
anagement  of  all  patients  in  the  current  series  were  dis-
ussed  in  a  MDT.  Furthermore,  the  overall  waiting  time  for
NT  clinic  appointment  in  our  institution  has  been  reducing,
n  keeping  with  current  guidelines.  The  average  period  from
ate  of  referral  to  surgery  differed  only  by  19  days  between
he  two  groups  and  this  may  also  explain  the  statistical
utcome.  A  3-year  review  of  over  1,100  2WW  referrals  in
 larger  cancer  centre  reported  that  only  21.4%  of  these
eferrals  were  positive  for  head  and  neck  cancer  [12]. When
ompared  with  routine  referral  routes,  McKie  et  al.  reported
hat  the  2WW  did  not  identify  more  early  stage  cancers
12]. Lyons  et  al.  also  found  that  71%  of  patients  diagnosed
ith  cancer  in  their  department  were  not  referred  by  the
ast  track  2WW  system  and  that  only  15%  of  patients  who
ere  referred  to  the  fast  track  system  were  subsequently
ound  to  have  cancer  [13]. A  structured  search  of  PubMed
evealed  that  most  published  studies  to  date  were  audits  of
ompliance  with  the  2WW  rule  [14—16].
linical  applicability  of  the  study
o  date,  few  UK  centres  have  published  outcomes  following
L.  Bajaj  et  al.  reviewed  outcomes  of  59  patients  over  a
-year  period  and  reported  that  5-year  survival  was  65.2%
17].  The  patient  cohort  also  varied  from  T1  to  T4,  which
as  similar  to  the  present  study.  The  results  in  this  study
ave  focused  speciﬁcally  on  survival  rates,  complications
nd  causes  of  death.  Quality  of  life  issues  were  not  evaluated
or  were  mortality  correlated  with  pre-existing  medical  co-
orbidities.  Survival  outcomes  in  patients  referred  under
he  2WW  for  suspicious  cancer  have  also  been  reported  in
his  study.  Similarities  in  survival  outcomes  with  other  stud-
es  do  not  negate  the  need  for  U.K.  speciﬁc  data  as  patient
ohorts  differ  between  these  studies.  Outcome  data  speciﬁc
o  the  population  being  treated  would  improve  our  ability  to
ouncil  patients  regarding  important  therapeutic  decisions
nd  end-of-life  issues.
Selection  criteria  for  TL  have  remained  the  same  through-
ut  the  review  period.  In  general,  patients  who  had  failed  RT
r  those  with  T3  tumours  of  the  larynx  or  hypopharynx  were
ligible  for  surgery.  Transoral  laser  resection  was  introduced
o  the  department  in  2003  and  some  patients  had  TL  after
ailed  TOLR.  The  treatment  protocol  for  RT  for  primary  car-
inoma  was  unchanged  throughout  the  period  of  the  study.
atients  who  had  pre-TL  tracheotomy,  T4  tumours,  neck
ode  involvement  (>  1  node,  >  2  cm,  extracapsular  spread)
ad  post-TL  RT.
rcin
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[Outcomes  following  total  laryngectomy  for  squamous  cell  ca
The  results  of  this  study  represent  the  cumulative  experi-
ence  of  TL  of  the  department  over  a  period  of  14  years.  The
study  cohort  comprised  of  four  groups:  laryngeal  or  hypopha-
ryngeal,  primary  treatment  or  salvage.  It  can  be  argued  that
to  make  better  sense  of  the  outcome,  it  would  be  better  to
consider  the  four  groups  individually.  However,  the  number
of  patients  in  each  group  was  relatively  small.  Furthermore,
the  aim  of  this  retrospective  review  was  to  evaluate  the  clin-
ical  outcomes  (survival  rate,  complications,  PCF)  following
TL,  rather  than  tumour  staging,  primary  site  or  outcomes
based  on  speciﬁc  treatment  modality.
Conclusions
While  there  is  an  increasing  tendency  towards  laryngeal
conservation,  TL  (primary  or  salvage)  remains  a  robust  treat-
ment  option  in  selected  patients.  This  treatment  modality
will  continue  to  form  part  of  the  armamentarium  of  treat-
ment  options  available  to  patients  treated  in  our  institution.
The  results  of  this  study  represent  the  clinical  outcome  of
a  cohort  of  patients  after  TL  from  the  perspective  of  a
district  general  hospital  in  the  United  Kingdom.  Unlike  pre-
vious  publications  which  have  focused  on  outcomes  based
on  tumour  staging,  we  have  presented  survival  probabili-
ties  following  TL.  Outcome  data  such  as  this  would  improve
our  ability  to  council  patients  regarding  important  thera-
peutic  decisions  and  end-of-life  issues.  Future  reports  from
this  department  would  examine  the  correlation  of  medical
co-morbidities  (ACE-27),  alcohol  and  smoking  with  survival
probabilities.
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